Bosentan tablet bulk supplier for pharma manufacturers

Bosentan Tablet 62.5 mg and 125 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 62.5 mg and 125 mg

Reference Brands: Tracleer®(US & EU)

Bosentan is an endothelin receptor antagonist that blocks the effects of endothelin-1, a substance causing blood vessel constriction. It relaxes pulmonary arteries, reducing blood pressure in PAH. Benefits include improved exercise capacity, decreased symptoms, and slowed disease progression in pulmonary arterial hypertension patients.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Bosentan tablets, marketed as Tracleer®, are approved in the US and EU for pulmonary arterial hypertension. Regulatory dossiers include extensive clinical trials, manufacturing compliance, and safety data, facilitating approval by FDA and EMA. These dossiers highlight bosentan’s efficacy in improving exercise capacity and reducing symptoms of PAH. The medication is available in 62.5 mg and 125 mg tablets, with dosing titrated based on patient response. For detailed insights on regulatory submissions, dossier requirements, and market approvals, visit PharmaTradz, your trusted source for pharmaceutical regulatory insights and industry updates.

Bosentan Tablet — third party manufacturing & bulk supply

Bosentan Tablet 62.5 mg and 125 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Bosentan Tablet is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Bosentan Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Bosentan Tablet →

Back to Listing

Frequently Asked Questions

Bosentan tablet is listed as Tablets in 62.5 mg and 125 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Bosentan tablet is referenced against Tracleer®(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.